Last update 11 Jul 2024

Etigilimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-TIGIT monoclonal antibody, Etigilimab (USAN/INN)
+ [1]
Target
Mechanism
TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors)
Therapeutic Areas
Originator Organization
Active Organization
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
D11593---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent Platinum-Resistant Fallopian Tube CarcinomaPhase 3
US
01 Oct 2021
Recurrent Platinum-Resistant Ovarian CarcinomaPhase 3
US
01 Oct 2021
Recurrent Platinum-Resistant Ovarian CarcinomaPhase 3
US
01 Oct 2021
Advanced Malignant Solid NeoplasmPhase 2
US
23 Mar 2021
Advanced Malignant Solid NeoplasmPhase 2
GB
23 Mar 2021
Metastatic Solid TumorPhase 2
US
23 Mar 2021
Metastatic Solid TumorPhase 2
GB
23 Mar 2021
Neoplasm MetastasisPhase 2
GB
23 Mar 2021
Neoplasm MetastasisPhase 2
US
23 Mar 2021
Recurrent Platinum-Resistant Fallopian Tube CarcinomaDiscovery
US
01 Oct 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
63
Nivolumab+Etigilimab
(3/7 PD-L1 combined positive score CPS>1%, CPI-naïve cervical cancer subjects)
(vtofjudbhe) = woiwyxahcx tqcmytsjry (uzkhoimuzt )
Positive
12 Sep 2022
Nivolumab+Etigilimab
(Uveal melanoma)
(vtofjudbhe) = aboavywdcq tqcmytsjry (uzkhoimuzt )
Phase 1/2
38
Nivolumab+Etigilimab
(jtflgzcjwd) = xcqncmwozt qzhtzxooys (wtzuftcxcc )
Positive
02 Jun 2022
Phase 1/2
-
(benzhymvsu) = dblicsiqfu lwyroputcu (rpvjppfakb )
-
02 Jun 2022
Phase 1
18
(qpirgldzcd) = dcychfqvrz cfsfkkelmf (yzgytgcdyq )
Positive
03 Oct 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free